Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 2
2012 3
2013 3
2014 2
2015 1
2017 1
2018 1
2019 1
2020 4
2021 5
2022 3
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction.
Lloberas N, Grinyó JM, Colom H, Vidal-Alabró A, Fontova P, Rigo-Bonnin R, Padró A, Bestard O, Melilli E, Montero N, Coloma A, Manonelles A, Meneghini M, Favà A, Torras J, Cruzado JM. Lloberas N, et al. Among authors: coloma a. Kidney Int. 2023 Oct;104(4):840-850. doi: 10.1016/j.kint.2023.06.021. Epub 2023 Jun 28. Kidney Int. 2023. PMID: 37391040 Clinical Trial.
Membranous nephropathy related to secondary syphilis.
Anton Pampols P, Espejo-Herrera N, Coloma A. Anton Pampols P, et al. Among authors: coloma a. Med Clin (Barc). 2021 Dec 24;157(12):596-597. doi: 10.1016/j.medcli.2021.01.018. Epub 2021 Apr 12. Med Clin (Barc). 2021. PMID: 33858673 English, Spanish. No abstract available.
The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations.
Fontova P, van Merendonk LN, Vidal-Alabró A, Rigo-Bonnin R, Cerezo G, van Oevelen S, Bestard O, Melilli E, Montero N, Coloma A, Manonelles A, Torras J, Cruzado JM, Grinyó JM, Colom H, Lloberas N. Fontova P, et al. Among authors: coloma a. Pharmaceutics. 2023 May 12;15(5):1481. doi: 10.3390/pharmaceutics15051481. Pharmaceutics. 2023. PMID: 37242723 Free PMC article.
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial.
Barratt J, Liew A, Yeo SC, Fernström A, Barbour SJ, Sperati CJ, Villanueva R, Wu MJ, Wang D, Borodovsky A, Badri P, Yureneva E, Bhan I, Cattran D; Cemdisiran Phase 2 Study Investigators and Collaborators. Barratt J, et al. Clin J Am Soc Nephrol. 2024 Apr 1;19(4):452-462. doi: 10.2215/CJN.0000000000000384. Epub 2024 Jan 15. Clin J Am Soc Nephrol. 2024. PMID: 38214599 Clinical Trial.
Clostridioides difficile infection recurrence in the VINCat hospitals: a prospective observational cohort study.
Pujol M, Limón E, Sopena N, Lopez-Contreras J, Castellá L, Cuquet J, López-Sánchez M, Pérez R, Gudiol C, Coloma A, Marimón M, Espinach J, Andres M, Martos P, Hernández S, Almendral A, Saliba P, Rodrigues GC, Calbo E, Group VP. Pujol M, et al. Among authors: coloma a. Future Microbiol. 2022 Dec;17:1445-1453. doi: 10.2217/fmb-2022-0076. Epub 2022 Oct 31. Future Microbiol. 2022. PMID: 36314417
Long-term impact of COVID-19 associated acute respiratory distress syndrome.
Aranda J, Oriol I, Martín M, Feria L, Vázquez N, Rhyman N, Vall-Llosera E, Pallarés N, Coloma A, Pestaña M, Loureiro J, Güell E, Borjabad B, León E, Franz E, Domènech A, Pintado S, Contra A, Cortés MDS, Chivite I, Clivillé R, Vacas M, Ceresuela LM, Carratalà J. Aranda J, et al. Among authors: coloma a. J Infect. 2021 Nov;83(5):581-588. doi: 10.1016/j.jinf.2021.08.018. Epub 2021 Aug 13. J Infect. 2021. PMID: 34400219 Free PMC article.
Persistent COVID-19 symptoms 1 year after hospital discharge: A prospective multicenter study.
Aranda J, Oriol I, Feria L, Abelenda G, Rombauts A, Simonetti AF, Catalano C, Pallarès N, Martín M, Vàzquez N, Vall-Llosera E, Rhyman N, Suárez RC, Nogué M, Loureiro-Amigo J, Coloma A, Ceresuela L, Carratalà J. Aranda J, et al. Among authors: coloma a. PLoS One. 2022 Oct 10;17(10):e0275615. doi: 10.1371/journal.pone.0275615. eCollection 2022. PLoS One. 2022. PMID: 36215250 Free PMC article.
Risk factors for non-diabetic renal disease in diabetic patients.
Bermejo S, González E, López-Revuelta K, Ibernon M, López D, Martín-Gómez A, Garcia-Osuna R, Linares T, Díaz M, Martín N, Barros X, Marco H, Navarro MI, Esparza N, Elias S, Coloma A, Robles NR, Agraz I, Poch E, Rodas L, Lozano V, Fernández B, Hernández E, Martínez MI, Stanescu RI, Moirón JP, García N, Goicoechea M, Calero F, Bonet J, Galceran JM, Liaño F, Pascual J, Praga M, Fulladosa X, Soler MJ. Bermejo S, et al. Among authors: coloma a. Clin Kidney J. 2020 Jan 3;13(3):380-388. doi: 10.1093/ckj/sfz177. eCollection 2020 Jun. Clin Kidney J. 2020. PMID: 32699618 Free PMC article.
Sustained Inhibition of Calcineurin Activity With a Melt-Dose Once-daily Tacrolimus Formulation in Renal Transplant Recipients.
Fontova P, Colom H, Rigo-Bonnin R, Bestard O, Vidal-Alabró A, van Merendonk LN, Cerezo G, Polo C, Montero N, Melilli E, Manonelles A, Meneghini M, Coloma A, Cruzado JM, Torras J, Grinyó JM, Lloberas N. Fontova P, et al. Among authors: coloma a. Clin Pharmacol Ther. 2021 Jul;110(1):238-247. doi: 10.1002/cpt.2220. Epub 2021 Mar 25. Clin Pharmacol Ther. 2021. PMID: 33626199 Free article. Clinical Trial.
34 results